| Literature DB >> 33996634 |
Leonardo G Lopes1, Larissa A Csonka1, Jessica A Souza Castellane1, Alef Winter Oliveira2, Sílvio de Almeida-Júnior2, Ricardo Andrade Furtado2, Cibele Tararam3, Larissa Ortolan Levy3, Leandro Zuccolotto Crivellenti4, Maria Luiza Moretti3, Maria José S Mendes Giannini5, Regina H Pires1.
Abstract
Aspergillus and Fusarium cause a broad spectrum of infections in humans, mainly in immunocompromised patients. Among these, patients undergoing hemodialysis are highly susceptible to infections, requiring a constant and adequate environmental disinfection program. Nevertheless, monitoring the residual disinfectants can contribute to the morbidity and mortality reduction in these patients. Here, we evaluated the susceptibility of Aspergillus spp. (n=19) and Fusarium spp. (n=13) environmental isolates against disinfectants (acetic acid, citric acid, peracetic acid, sodium hypochlorite, and sodium metabisulphite) at different concentrations and time exposures. Also, we investigated the in vivo toxicity of the peracetic acid residual concentration in mice. Fusarium isolates were identified by F. equiseti, F. oxysporum and F. solani while Aspergillus presented clinically relevant species (A. fumigatus, A. niger and A. terreus) and environmental ones. Against planktonic cells, only two disinfectants (acetic acid and sodium hypochlorite) showed a fungicidal effect on Fusarium spp., while only one (sodium hypochlorite) was effective against Aspergillus spp. Both fungi formed robust in vitro biofilms with large amounts of the extracellular matrix, as evidenced by electron micrographs. Exposure of fungal biofilms to disinfectants showed sensitivity to three (acetic, citric, and peracetic acids), although the concentrations and times of exposure varied according to the fungal genus. Mice exposure to the residual dose of peracetic acid during 60 weeks showed anatomopathological, hematological, and biochemical changes. The implementation of news control measures and those that already exist can help reduce infections, the second cause of death and morbidity in these patients, besides providing safety and well-being to them, a priority of any quality health program.Entities:
Keywords: Aspergillus; Fusarium; biofilm; disinfectant; mice
Mesh:
Substances:
Year: 2021 PMID: 33996634 PMCID: PMC8116949 DOI: 10.3389/fcimb.2021.663741
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
The sequence of primers used for sequencing environmental Fusarium and Aspergillus isolates.
| Species | Gene | Protein | Primer | Reference | |
|---|---|---|---|---|---|
| Name | Sequence (5´-3’) | ||||
|
|
| Translation elongation factor 1 alpha | HS392 | TCAAAATGGGTAAGGA(A/G)GACAAGAC |
|
| HS393 | GCCTGGGA(A/G)GTACCAGT(C/G)ATCATGTT |
| |||
| EF11 | GTGGGGCATTTACCCCGCC |
| |||
| EF21 | GAGTGGCGGGGTAAATGCC |
| |||
| rDNA | Ribosomal DNA | ITS4 | TCCTCCGCTTATTGATATGC |
| |
| ITS5 | GGAAGTAAAAGTCGTAACAAGG |
| |||
| NL1 | GCATATCAATAAGCGGAGGAAAAG |
| |||
| NL4 | GGTCCGTGTTTCAAGACGG |
| |||
|
|
| ß-tubulin | 2A | GGTAACCAAATCGGTGCTGCTTTC |
|
| 2B | ACCCTCAGTGTAGTGACCCTTGGC |
| |||
|
| Calmodulin | CMD5 | CCGAGTACAAGGAGGCCTTC |
| |
| CMD6 | CCGATAGAGGTCATAACGTGG |
| |||
Y: C or T; W: A or T; R: A or G; K: G or T; S: G or C; D: A, G or T; B: G, T or C; H: A, C or T.
Figure 1Distribution of the Fusarium (A) and Aspergillus (B) strains among complexes or sections. Legend: FOSC - Fusarium oxysporum species complex, FSSC - Fusarium solani species complex, FIESC - Fusarium incarnatum-equiseti species complex.
Molecular identification of species of Fusarium and Aspergillus.
| ID | Molecular Identification | Complex/Section |
|---|---|---|
| F1 |
| FOSC |
| F3 |
| FSSC |
| F4 |
| FOSC |
| F5 |
| FOSC |
| F6 |
| FSSC |
| F7 |
| FSSC |
| F8 |
| FOSC |
| F9 |
| FSSC |
| F10 |
| FOSC |
| F11 |
| FIESC |
| F12 |
| FOSC |
| F13 |
| FSSC |
| F14 |
| FSSC |
| A1 |
| Nigri |
| A3 |
| Fumigati |
| A4 |
| Terrei |
| A5 |
| Nigri |
| A6 |
| Nigri |
| A7 |
| Flavi |
| A8 |
| Flavi |
| A9 |
| Circumdati |
| A10 |
| Nigri |
| A11 |
| Nigri |
| A12 |
| Nigri |
| A13 |
| Nigri |
| A14 |
| Flavi |
| A16 |
| Versicolores |
| A17 |
| Nigri |
| A18 |
| Nigri |
| A19 |
| Flavi |
| A20 |
| Versicolores |
| A21 |
| Fumigati |
| A22 |
| Nigri |
| A23 |
| Flavi |
FOSC, Fusarium oxysporum species complex; FSSC, Fusarium solani species complex; FIESC, Fusarium incarnatum-equiseti species complex.
Disinfectants activities against Fusarium planctonic cells.
| Disinfectant | Origin | Final concentration tested | Exposure time | Control (CFU/ml ± SD) | Control (Log10) | Treated (CFU/ml ± SD) | Treated (Log10) |
|---|---|---|---|---|---|---|---|
| Glacial acetic acid | Synth, SP, Brazil | 1% (v/v) | 30 min | 1.59x104 ± 2.5x102 | 4.2 |
|
|
| Citric acid | Bell Citric 50®, Presidente Prudente, SP, Brazil | 1% (v/v) | 120 min | 1.56x104 ± 2.1x102 | 4.19 | 6.15x102 ± 1.42x10 | 2.78 |
| 21% (v/v) | 40 min | 1.96x104 ± 1.94x102 | 4.29 | 7.18x102 ± 1.34x10 | 2.85 | ||
| 50% (v/v) | 15 min | 1.80x104 ± 2.3x102 | 4.25 | 3.96x102 ± 1.10x10 | 2.59 | ||
| Peracetic acid | Puristeril 340®, Fresenius Medical Care, Jaguariuna, SP, Brazil | 0.1% (v/v) | 30 min | 1.88x104 ± 2.2x102 | 4.27 | 1.10x103 ± 2.10x102 | 3.03 |
| 0.2% (v/v) | 10 min | 1.96x104 ± 1.8x102 | 4.29 | 2.08x103 ± 3.04x102 | 3.31 | ||
| Sodium hypochlorite | 12%, Solynt, Guarulhos, SP, Brazil | 0.05% (v/v) | 30 min | 1.76x104 ± 2.4x102 | 4.24 | 1.18x103 ± 4.20x102 | 3.07 |
| 0.1% (v/v) | 10 min | 1.82x104 ± 2.1x102 | 4.26 | 1.18x103 ± 3.84x102 | 3.07 | ||
| 2.5% (v/v) | 30 min | 1.76x104 ± 2.3x102 | 4.24 |
|
| ||
| Sodium metabisulphite | Synth, SP, Brazil | 0.1% (w/v) | 120 min | 1.64x104 ± 1.9x102 | 4.21 | 2.92x103 ± 4.14x102 | 3.46 |
CFU/ml, Colony Forming Unit per milliliter. Bold numbers denote disinfectant activity.
Disinfectants activities against Aspergillus plactonic cells.
| Disinfectant | Origin | Final concentration tested | Exposure time | Control (CFU/ml ± SD) | Control (Log10) | Treated (CFU/ml ± SD) | Treated (Log10) |
|---|---|---|---|---|---|---|---|
| Glacial acetic acid | Synth, SP, Brazil | 1% (v/v) | 30 min | 2.5x104 ± 2.1x103 | 4.39 | 2.44x103 ± 2.46x102 | 3.43 |
| Citric acid | Bell Citric 50®, Presidente Prudente, SP, Brazil | 1% (v/v) | 120 min | 2.4x104 ± 2.6x103 | 4.38 | 1.89x103 ± 2.08x102 | 3.27 |
| 21% (v/v) | 40 min | 2.6x104 ± 2.5x103 | 4.41 | 1.70x103 ± 3.21x102 | 3.22 | ||
| 50% (v/v) | 15 min | 2.5x104 ± 1.7x103 | 4.39 | 1.08x103 ± 1.53x102 | 3.03 | ||
| Peracetic acid | Puristeril 340®, Fresenius Medical Care, Jaguariuna, SP, Brazil | 0.1% (v/v) | 30 min | 2.4x104 ± 2.2x103 | 4.38 |
| 2.62 |
| 0.2% (v/v) | 10 min | 2.5x104 ± 1.7x103 | 4.39 | 1.48x103 ± 2.24x102 | 3.17 | ||
| Sodium hypochlorite | 12%, Solynt, Guarulhos, SP, Brazil | 0.05% (v/v) | 30 min | 2.5x104 ± 1.6x103 | 4.39 | 4.36x103 ± 3.51x102 | 3.63 |
| 0.1% (v/v) | 10 min | 2.5x104 ± 1.6x103 | 4.39 | 3.28x103 ± 3.70x102 | 3.51 | ||
| 2.5% (v/v) | 30 min | 2.4x104 ± 1.5x103 | 4.38 |
|
| ||
| Sodium metabisulphite | Synth, SP, Brazil | 0.1% (w/v) | 120 min | 2.4x104 ± 1.5x103 | 4.38 | 1.23x103 ± 2.44x102 | 3.09 |
CFU/ml, Colony Forming Unit per milliliter; Bold numbers denote disinfectant activity.
Figure 2Representative micrographs of the Aspergillus (A – A.niger; B – A. terreus) and Fusarium oxysporum (C) biofilms.
Disinfectants activities against Aspergillus and Fusarium biofilm cells.
| Disinfectant | Origin | Final concentration tested | Exposure time |
|
| ||
|---|---|---|---|---|---|---|---|
| Control (OD 492nm) | Treated (OD 492nm) | Control (OD 492nm) | Treated (OD 492nm) | ||||
| Glacial acetic acid | Synth, SP, Brazil | 1% (v/v) | 30 min | 1.45 ± 0.08 | 0.40 ± 0.06 | 1.82 ± 0.07 |
|
| Citric acid | Bell Citric 50®, Presidente Prudente, SP, Brazil | 1% (v/v) | 120 min | 1.42 ± 0.11 | 0.70 ± 0.06 | 1.80 ± 0.03 | 0.87 ± 0.01 |
| 21% (v/v) | 40 min | 1.44 ± 0.08 | 0.53 ± 0.13 | 1.84 ± 0.16 | 0.72 ± 0.10 | ||
| 50% (v/v) | 15 min | 1.42 ± 0.09 |
| 1.82 ± 0.08 |
| ||
| Peracetic acid | Puristeril 340®, Fresenius Medical Care, Jaguariuna, SP, Brazil | 0.1% (v/v) | 30 min | 1.41 ± 0.13 |
| 1.82 ± 0.21 | 0.43 ± 0.11 |
| 0.2% (v/v) | 10 min | 1.41 ± 0.09 |
| 1.81 ± 0.17 |
| ||
| Sodium hypochlorite | 12%, Solynt, Guarulhos, SP, Brazil | 0.05% (v/v) | 30 min | 1.46 ± 0.14 | 0.77 ± 0.09 | 1.84 ± 0.26 | 0.97 ± 0.10 |
| 0.1% (v/v) | 10 min | 1.40 ± 0.20 | 0.73 ± 0.02 | 1.81 ± 0.23 | 0.77 ± 0.15 | ||
| 2.5% (v/v) | 30 min | 1.45 ± 0.14 |
| 1.81 ± 0.19 |
| ||
| Sodium metabisulphite | Synth, SP, Brazil | 0.1% (w/v) | 120 min | 1.45 ± 0.24 | 0.69 ± 0.18 | 1.82 ± 0.13 | 0.50 ± 0.10 |
Bold numbers denote 80% reduction or more when compared to control.
Comparative summary of histopathological analysis between the different organs of the animals groups studied (n = 15).
| Organ | Architecture | Inflammation | Necrosis | Hemorrhage | Congestion | Hyperemia | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CT | SS | DSF | CT | SS | DSF | CT | SS | DSF | CT | SS | DSF | CT | SS | DSF | CT | SS | DSF | |
|
| Normal | Normal | Discrete degeneration | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Discreet and | Absent | Absent | Absent |
|
| Normal | Normal | Normal | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent |
|
| Normal | Normal | Normal | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent |
|
| Normal | Normal | Emphysema areas in | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Discreet and | Discreet and | Absent | Absent | Discreet |
|
| Normal | Normal | Normal | Absent | Absent | Absent | Absent | Absent | Discreet | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent |
|
| Normal | Normal | Lymphoid hyperplasia | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Discreet and | Discreet and | Absent | Absent | Discreet |
|
| Normal | Normal | Follicular hyperplasia | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent | Absent |
Groups: CT, Control; SS, Saline Solution; DSF, Disinfectant.
Figure 3Biochemical values obtained for the groups of mice studied (CT = control group; SS = treated with sterile saline and DSF = group treated with 1 ppm peracetic acid). The results are expressed as mean and standard deviation. *p < 0.05.
Figure 4Hematological values obtained for the groups of mice studied (CT = control group; SS = treated with sterile saline and DSF = group treated with 1 ppm peracetic acid). The results are expressed as mean and standard deviation. *p < 0.05.